- Home
- Publications
- Publication Search
- Publication Details
Title
BET bromodomains’ functions in bone-related pathologies
Authors
Keywords
-
Journal
Epigenomics
Volume 12, Issue 2, Pages 127-144
Publisher
Future Medicine Ltd
Online
2019-12-18
DOI
10.2217/epi-2019-0172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
- (2018) Guillaume P. Andrieu et al. MOLECULAR CANCER RESEARCH
- Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
- (2018) Fred C. Lam et al. Nature Communications
- Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts
- (2017) Yuankun Zhai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling
- (2017) Huan-Tian Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Bromodomains: Structure, function and pharmacology of inhibition
- (2016) Elena Ferri et al. BIOCHEMICAL PHARMACOLOGY
- Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth
- (2016) Ningning Niu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
- (2016) H. K. Bid et al. MOLECULAR CANCER THERAPEUTICS
- Skeletal phenotypes in adult patients with osteogenesis imperfecta—correlations with COL1A1/COL1A2 genotype and collagen structure
- (2016) J. D. Hald et al. OSTEOPOROSIS INTERNATIONAL
- Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
- (2016) Camille Jacques et al. Oncotarget
- BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma
- (2016) Sudan N. Loganathan et al. Oncotarget
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis
- (2015) Bebeka Gjoksi et al. BONE
- Coamplification ofMyc/Pvt1and homozygous deletion ofNlrp1locus are frequent genetics changes in mouse osteosarcoma
- (2015) Pulivarthi H. Rao et al. GENES CHROMOSOMES & CANCER
- The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma
- (2015) David A. Liebner JOURNAL OF SURGICAL ONCOLOGY
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7
- (2015) Zhen Xue et al. PLoS One
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
- (2015) L. Mirabello et al. Cancer Discovery
- Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
- (2015) Tim Hensel et al. Oncotarget
- BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
- (2015) Emma K Baker et al. Scientific Reports
- Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma
- (2015) Kaishun Hu et al. Oncotarget
- Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) ANNALS OF ONCOLOGY
- The bromodomain: From epigenome reader to druggable target
- (2014) Roberto Sanchez et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
- (2014) Jian Shi et al. CANCER CELL
- Histone variants: key players of chromatin
- (2014) Burcu Biterge et al. CELL AND TISSUE RESEARCH
- An epigenomic approach to therapy for tamoxifen-resistant breast cancer
- (2014) Qin Feng et al. CELL RESEARCH
- A mechanistic link between gene regulation and genome architecture in mammalian development
- (2014) Giancarlo Bonora et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
- (2014) Dhong Hyun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction
- (2014) S. Meng et al. JOURNAL OF DENTAL RESEARCH
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- Li-Fraumeni syndrome: cancer risk assessment and clinical management
- (2014) Kate A. McBride et al. Nature Reviews Clinical Oncology
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response
- (2014) M Hussong et al. Cell Death & Disease
- Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation
- (2014) Kyung-Hyun Park-Min et al. Nature Communications
- Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle
- (2014) François Lamoureux et al. Nature Communications
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
- (2013) M. F. Segura et al. CANCER RESEARCH
- Stable Pausing by RNA Polymerase II Provides an Opportunity to Target and Integrate Regulatory Signals
- (2013) Telmo Henriques et al. MOLECULAR CELL
- Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
- (2013) Shwu-Yuan Wu et al. MOLECULAR CELL
- The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
- (2013) Scott R. Floyd et al. NATURE
- Genome-wide association study identifies two susceptibility loci for osteosarcoma
- (2013) Sharon A Savage et al. NATURE GENETICS
- Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
- (2013) Z Zou et al. ONCOGENE
- FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
- (2013) Laura Christensen et al. PLoS One
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B
- (2012) P. Garcia-Gutierrez et al. JOURNAL OF CELL SCIENCE
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- ATP-dependent chromatin remodeling: genetics, genomics and mechanisms
- (2011) Diana C Hargreaves et al. CELL RESEARCH
- A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes
- (2011) Jagat C. Borah et al. CHEMISTRY & BIOLOGY
- The Epigenotype
- (2011) C. H. Waddington INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
- (2011) S. Rahman et al. MOLECULAR AND CELLULAR BIOLOGY
- Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
- (2011) J. M. Lamonica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines
- (2011) YI ZHANG et al. Oncology Letters
- FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing’s sarcoma cells
- (2010) Liu Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The molecular pathogenesis of Ewing sarcoma
- (2010) Carlos Mackintosh et al. CANCER BIOLOGY & THERAPY
- Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2
- (2010) Zachary Charlop-Powers et al. CELL RESEARCH
- Downstream EWS/FLI1 - upstream Ewing's sarcoma
- (2010) Heinrich Kovar Genome Medicine
- The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis
- (2009) Aron Gyuris et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss ofCdkn2
- (2009) Alexander B Mohseny et al. JOURNAL OF PATHOLOGY
- Osteopetrosis due to Homozygous Chloride Channel ClCN7 Mutation Mimicking Metabolic Disease with Haematological and Neurological Impairment
- (2009) D. Furthner et al. KLINISCHE PADIATRIE
- Cooperative binding of two acetylation marks on a histone tail by a single bromodomain
- (2009) Jeanne Morinière et al. NATURE
- A Molecular Function Map of Ewing's Sarcoma
- (2009) Maximilian Kauer et al. PLoS One
- Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades
- (2008) Natia Esiashvili et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells
- (2008) E García-Aragoncillo et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More